Psychedelic medicine for women, by women.

The first female focused and founded psychedelic medicine biotech company.

Contact Us

We aim to elevate women’s health and autonomy, with Aphrodite Health's novel psychedelic medicine, all rooted in evidence-based medicine.

By developing targeted psychedelic therapeutics, we address the unmet medical needs of women with chronic pain and hormone-related mood disorders commonly overlooked by modern medicine.

Patient Recognition

Women are underserved and often ignored in today's healthcare market.

Female Focused

Female's want and deserve products that are created to be gender specific.

Problem Solving

We bring new solutions, creative thinking, and novel therapeutics to solve these issues.

Positive Change

Let's disrupt the existing antidepressant market.

The global antidepressant market is set to reach $21.28 billion by 2025. We want to shift towards a more natural and beneficial solution for those in need.

Addressing female hormone related mood disorders (FHRMD).

Women are 2.5 times more likely to take an antidepressant than men, in any age group.

Read More

Addressing chronic pain in the female body.

Women experience more intense pain and for longer periods of time.

Read More


Mood Disorders

Cyclical changes in estrogen, progesterone and other hormones can disrupt the function of brain chemicals such as serotonin that control mood. While these changes are normal, some hormonal fluctuations increase the risk of developing severe and disabling forms of depression during puberty, postpartum and perimenopause.

Chronic Pain

According to the International Association for the Study of Pain; chronic pain affects a higher proportion of women than men around the world; however women are less likely to receive treatment. Research has shown that women generally experience more recurrent, more severe pain and longer lasting pain.


Women with chronic pain and mood disorders often have other symptoms including irritability, insomnia, anxiety and memory symptoms that are neglected. The current treatments including NSAIDS, SSRIs and opioids are ineffective and potentially addictive.


SSRIs are not always effective to treat PMS and PMDD, and can have side effects that make treatment difficult to follow long-term. Biomedical treatments achieve only modest benefits for pain and sexual functioning in women.


Mood disorder mechanisms in PMS and PMDD are poorly understood. Treatment protocols can include hormonal contraception, change in diet, change in daily exercise, cognitive therapy or SSRIs, without knowing the rationale between these combination treatments.

Putting Women's Health First

Our product strategy is developing an Active Pharmaceutical Ingredient (API) that will enable us to enter new markets with high efficiency.

Learn More